TANDY MARTIN: Open Payments
NPI 1679913099 · HATTIESBURG, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$615 in 32 payments from 15 companies in 2025. Trend: 2023 $925 · 2024 $606 · 2025 $615
Food & beverage: $615
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 8 | $156 |
| Dendreon Pharmaceuticals LLC | 4 | $74 |
| Sumitomo Pharma America, Inc. | 4 | $67 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $58 |
| TOLMAR, INC. | 2 | $43 |
| Siemens Medical Solutions USA, Inc. | 2 | $40 |
| Merck Sharp & Dohme LLC | 1 | $25 |
| Pacira Pharmaceuticals Incorporated | 1 | $23 |
| PROGENICS PHARMACEUTICALS, INC. | 1 | $21 |
| Cycle Pharmaceuticals Inc | 1 | $20 |
Products named: ERLEADA, PROVENGE, Nubeqa, GEMTESA, ORGOVYX, ELIGARD, KEYTRUDA, Exparel.
Industry payments across MS — which companies pay providers there.
